INTRODUCTION
Small bowel adenocarcinoma (SBA) is an extremely rare tumor, accounting for <2% of all gastrointestinal tumors. Its annual incidence rate is 1.2-6.5/1 million people. [3] SBA occurs on the duodenum in 57% of cases, jejunum in 29%, and the ileum in 10%. [3] Inflammatory bowel diseases, such as Crohn's disease, and polyposis, such as familial adenomatous polyposis, are risk factors for SBA. [10] We report a very rare case of brain metastasis from poorly differentiated SBA.
www.surgicalneurologyint.com
Surgical Neurology International
Editor-in-Chief: Nancy E. Epstein, MD, NYU Winthrop Hospital, Mineola, NY, USA.
CASE REPORT
A 54-year-old man who suffered from abdominal pain and melena visited a nearby hospital. He had a medical history of hyperlipidemia and diabetes but had no risk factors for SBA. After clinical evaluation, a jejunum tumor was suspected. In July 2017, he underwent partial resection of the jejunum with regional lymphadenectomy and combined resection of the transverse colon. e transverse colon was attached to the jejunum tumor and they could not be separated. In August 2017, he was referred to our hospital for the purpose of adjuvant treatment. However, due to a liver metastasis detected by a computed tomography (CT) scan at the time of admittance, palliative chemotherapy using capecitabine and oxaliplatin (CAPOX) was selected. However, the efficacy of CAPOX and second-line FOLFIRI (5-fluoropyrimidine/ leucovorin/irinotecan) chemotherapy was limited.
In April 2018, during the course of the third-line chemotherapy using nab-paclitaxel, he presented with dizziness, followed by headache, nausea, and ataxia symptoms which were remarkable. Magnetic resonance imaging (MRI) revealed a cystic lesion with a major axis of 38 mm attached to the tent in the left cerebellum. e lesion had weak contrast effect and was accompanied by edema.
Tumor resection was performed for symptom control. e contents of the cyst were old brownish hematoma-like liquid with nodular lesions. Pathological findings of the primary jejunum tumor were reviewed. e jejunum tumor was poorly differentiated adenocarcinoma resembling cerebellum tumor. Squamous differentiation was limited, observed in part of the tumor. Immunohistochemically, the jejunum tumor cells were positive for cytokeratin (CK) 7, CK8, hepatocyte nuclear factor 4α (HNF4α), vimentin, and p40 (partially positive on cancer cells with squamous differentiation). ey were negative for CK20, thyroid transcription factor 1, and caudaltype homeobox protein 2 (CDX2). Next-generation DNA sequencing (NGS) of primary lesions showed a KRAS codon 12 mutation, which is the most frequent genetic alteration of SBA. Based on surgical, radiological, pathological, and genetic findings, this brain tumor was comprehensively diagnosed as a metastasis from poorly differentiated SBA.
Postoperative MRI revealed total removal of the tumor; thus, according to the results of the JCOG 0504 trial, we chose close observation without additional radiotherapy [ Figures 2c-f and 3a] . [4] After the surgery, his general condition was improved, and he was discharged from our hospital without any neurological deficits. 
DISCUSSION
e breakdown of small bowel malignancies in the United States is 37.4% neuroendocrine tumor, 36.9% adenocarcinomas, 8.4% stromal tumors, and 17.3% lymphomas. [1] e most common organs of SBA metastases are the abdominal lymph node, liver, and peritoneum; there have been almost no reports on brain metastases of SBA. [2, 3, 5, 9] Dabaja et al. reported 1 case of brain metastasis out of 217 SBA cases, but details of the clinical course of the case were unclear. [2] Salvati et al. reported 10 cases of cerebral metastases from small intestine carcinoma, though no information about the clinical features of small intestine carcinoma was reported. [9] Our case might be the first report covering the full clinical course, pathological findings, and genetic data. In this case, the jejunum tumor was diagnosed as a primary lesion of brain tumor by surgical, radiological, pathological, and genetic findings. Although brain metastases typically show strong contrast enhancement, our SBA metastatic lesion was characteristic in its weak contrast effect. Postgadolinium MRI of SBA is reported to demonstrate heterogeneous and moderate enhancement. [7] Our case was poorly differentiated adenocarcinoma and this might be one of the MRI findings of SBA.
Immunohistochemically, the jejunum tumor was HNF4α positive and CDX2 negative. HNF4α is consistent with poorly differentiated adenocarcinoma of the gastrointestinal tract. CDX2 is usually positive in differentiated SBA, but in undifferentiated types, the positive rate drops to 58%. us, this finding might not be contradictory to the standard immunohistochemistry of poorly differentiated SBA. [8] CK8 expression is characteristic of adenocarcinoma. In typical SBA, CK7 is negative and CK20 is positive. is case was CK7 positive and CK20 negative, corresponding to 13% of SBA cases. [8] Vimentin expression suggests poor differentiation. P40 was partially positive, which indicates partial differentiation to squamous carcinoma. 
